but Novo Nordisk is trying to change that. The Danish drugmaker has reported the first phase 3 results with its new basal insulin product – insulin icodec – which backs up earlier data ...
Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.
Changing from gas to climate-friendly electric appliances often involves expensive retrofits. A growing list of companies ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
The FDA has now cleared the Magstim Horizon 3.0 and Inspire Transcranial Magnetic Stimulation ... and Adolescent Depression with a single treatment coil.” Practices with current Magstim Horizon ...
After hours: March 20 at 5:28:02 PM EDT Loading Chart for SYK ...
Pre-Market: 5:54:38 a.m. EDT Loading Chart for SYK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback